All News

Cangrealor is the first FDA-approved P2Y12 inhibitor.

How Walgreens is helping pharmacists be more involved than ever in helping cancer patients.

A look at PDMPs in PA-what they are doing and how they are helping patients.

Noctiva is the first agent approved to temporarily decrease urine production in adults with nocturia from various causes.

Former FDA deputy commissioner is nominated to take the top job, but financial ties may bind for him.

Small doses is a weekly slideshow of the news you may have missed, made just for you and your busy lifestyle.

A Midwest pharmacy chain is creating an adherence program to help its patients with diabetes.

Celebrate Women's History Month with us! Take a look back to where we have come from and where we still need to go.

How a diabetes clinic that includes a collaboration between an endocrinologist and a pharmacist can produce thousands of dollars in health-care savings.

Analysts and columnists from the left and right have had time to react to the new healthcare replacement plan. What are they saying?

Jonathan C. Roberts is named Executive Vice President and COO.

Meijer will improve and expand pharmacies across its new and remodeled stores.

A meta-analysis casts light on therapy compliance issues among patients with different mental health disorders.

A new study finds that patients many patients prefer cannabis to prescribed opioids.

If your patients are grumpy on Sundays and happy on Thursdays, you may not be alone.

An ageing population and an increase in government spending mean that NHE will only be growing in the coming decade.

New express lanes are designed to make it easier for customers to quickly fill their prescriptions.

In his address to Congress, Trump hinted at what could be in the future for healthcare reform.

A Pfizer plant in Kansas is putting patients at risk, according to the FDA

Rite Aid and Albertsons expand naloxone Access, hoping to curb the opioid epidemic.

Rare Disease Day is held every year on the last day of February to help spread awareness about rare diseases and the people they impact.

A look at four important drug studies and stories that you need to know about.

How the new Trump administration will affect everything from the ACA to the FDA.

Bills have been introduced in both the Senate and House that are aimed at stopping direct and indirect remuneration fees, assuming they are passed.

IPC and Pace Alliance join together to help the independent pharmacist.

The Associated Press is reporting that federal authorities are ramping up investigations at VA and federal medical centers due to an increase in diversion of opioids and other problems.

A pharmacy in Pennsylvania allowed a man to pick up his mother's prescription for fentanyl after being told not to allow it, with tragic results.

GPhA, the generic drug industry’s leading trade organization, adopted a new name: the Association for Accessible Medicines (AAM). The new name reflects the organization's mission “to make more medicines more accessible to more people who need them.”